Tharimmune appoints global business executive david h. clarke as key strategic advisor

Bridgewater, nj / accesswire / july 17, 2024 / tharimmune, inc. (nasdaq:thar) ("tharimmune" or the "company"), a clinical-stage biotechnology company developing a portfolio of therapeutic candidates in inflammation and immunology, announces the appointment of david h. clarke as a strategic advisor to the company's executive management team.
THAR Ratings Summary
THAR Quant Ranking